CORO2A and triple-negative breast carcinoma: A recent study showed that expression of CORO2A was associated with overall survival and relapse-free survival in patients with triple-negative breast cancer; moreover, knockdown of CORO2A reduced malignant transformation and induced cell cycle arrest [41].